Taiwan FDA registration 4aeb8e8ea3e0605cc9feb3ca0fb578ed

"Siemens" High Sensitivity Cardiac Troponin I Test Kit

TW: "西門子" 高靈敏度心肌肌鈣蛋白 I 檢驗試劑盒
Taiwan flagTaiwan·Risk Class 2·SIEMENS HEALTHCARE DIAGNOSTICS INC.·Registered Oct 05, 2023 – Oct 05, 2028Active
Registration details
Analysis ID
4aeb8e8ea3e0605cc9feb3ca0fb578ed
Customs Code
DHA05603622805
Company information
Manufacturer Country
United States
Authorized Representative
SIEMENS HEALTHCARE LIMITED
Product details
Intended Use
This product is intended for in vitro diagnostic use for the quantitative determination of cardiac troponin I (cTnI) in human microvascular (finger prick) whole blood and lithium heparin, venous whole blood or plasma in combination with the Atellica VTLi Immunoassay Analyzer.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1215 Creatine phosphokinase/creatine kinase or isoenzyme testing system
Import Information
QMS/QSD;; 輸入
Dates and status
Registration Date
Oct 05, 2023
Expiry Date
Oct 05, 2028
About this record

Access comprehensive regulatory information for "Siemens" High Sensitivity Cardiac Troponin I Test Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4aeb8e8ea3e0605cc9feb3ca0fb578ed and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices